PFIZER has confirmed there are only two bidders remaining for its consumer products division, with GlaxoSmithKline and Reckitt Benckiser still having their hats in the ring, according to a Bloomberg report in the US on the weekend.
Brands up for grabs include Advil, ChapStick, Centrum and more, with GSK and RB set to gain access to Pfizer's data room to begin due diligence before submitting final offers in the next few weeks.
The deadline for non-binding offers for the business was 01 Feb, with the deal estimated to be worth US$15-$20 billion.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Feb 18